BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation Feasibility.

Candan O, Buyukkurkcu B, Karti S, Uzay A

Open source

DOI
10.3390/medicina62081502
Published
2026 Aug 5
Container
Medicina (Kaunas, Lithuania)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina62081502,
  title = {BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation Feasibility.},
  author = {Candan O and Buyukkurkcu B and Karti S and Uzay A},
  year = {2026},
  journal = {Medicina (Kaunas, Lithuania)},
  doi = {10.3390/medicina62081502},
  url = {https://doi.org/10.3390/medicina62081502}
}

RIS

TY  - JOUR
TI  - BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation Feasibility.
AU  - Candan O
AU  - Buyukkurkcu B
AU  - Karti S
AU  - Uzay A
PY  - 2026
JO  - Medicina (Kaunas, Lithuania)
DO  - 10.3390/medicina62081502
UR  - https://doi.org/10.3390/medicina62081502
ER  - 

APA

O, C., B, B., S, K., & A, U. (2026). BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation Feasibility.. Medicina (Kaunas, Lithuania). https://doi.org/10.3390/medicina62081502

Source records